胎儿窦性心动过缓相关的潜在致死性心脏疾病:34例分析
回顾性分析34例持续性胎儿窦性心动过缓(FSB)病例的产前及产后结局。产后诊断包括长QT综合征、窦房结功能障碍、心肌病等多种严重心脏疾病。提示FSB可能是潜在致死性心脏疾病的早期表现,需产前产后系统评估及家系筛查。
要点
- 持续性FSB需警惕遗传性心律失常、心肌病及窦房结功能障碍。
- FSB伴结构异常或家族史者,建议产后心电图、Holter及基因检测。
- 对确诊遗传性心律失常的先证者家系成员应进行级联筛查。
核心结论
- FSB可能是遗传性心律失常综合征、心肌病和窦房结功能障碍等严重基础心脏疾病的首发表现。
- 级联检测可识别高危一级亲属,有助于及时干预和适当管理。
研究设计与样本
- 本研究为回顾性研究,纳入2014年1月至2024年12月英国伦敦Brompton胎儿心脏中心诊断的34例持续性FSB病例。
- FSB定义为至少连续两次胎儿超声心动图上胎心率低于同孕周第3百分位数且房室传导为1:1。
- 排除心房异构病例,纳入心脏结构正常及合并先天性心脏病但内脏心房位置正常的胎儿。
- 产后评估包括12导联心电图、超声心动图、24小时动态心电图、基因检测及最终诊断。
关键影像表现/征象
- 34例中7例合并结构性心脏异常,包括双心室肥厚、肥厚型心肌病、左心发育不良综合征、双侧上腔静脉、左心室心肌致密化不全及小型室间隔缺损。
- 产后最终诊断包括长QT综合征10例、窦房结功能障碍6例、左心室心肌致密化不全2例、Albright遗传性骨营养不良伴甲状腺功能减退2例。
- 其余产后诊断包括组织细胞样心肌病、儿茶酚胺敏感性多形性室性心动过速及强直性肌营养不良各1例。
诊断标准与关键数值
- FSB诊断标准为胎心率低于同孕周第3百分位数,且至少连续两次胎儿超声心动图显示房室传导为1:1。
- 22例获得基因报告,7例KCNQ1突变,3例KCNH2突变,2例GNAS1突变,NDUFB11、RYR2、CDH7、DMPK各1例突变。
- 4例de novo长QT综合征中2例及1例儿茶酚胺敏感性多形性室性心动过速通过级联检测发现患病家族成员。
临床应用与阅片要点
- 转诊指征包括胎儿心动过缓、可疑先天性心脏病、母体抗Ro抗体阳性及长QT综合征、心肌病或先天性心脏病家族史。
- 胎儿超声发现持续性FSB时应详细评估心脏结构及节律,并随访胎心率变化。
- 仅1例抗Ro相关窦房结功能障碍患儿在4岁时需要起搏器治疗。
- 产后对FSB婴儿应常规进行心电图和Holter监测以排除隐匿性心律失常。
局限性
- 本研究为单中心回顾性设计。
- 34例中11例产后最终分类为「正常」,可能受限于检测手段或随访时长。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Fetal sinus bradycardia (FSB) is usually a benign antenatal finding but it can be a marker of an underlying serious condition that manifests in later life. The aim of this study was to report the antenatal course and postnatal outcome of FSB.
METHOD: This study was a retrospective review of all cases of persistent FSB, defined as a fetal heart rate (FHR) < 3rd percentile for gestational age (GA) with 1:1 atrioventricular conduction on at least two consecutive fetal echocardiograms, diagnosed between January 2014 and December 2024 at the Brompton Centre for Fetal Cardiology, London, UK. Cases of isomerism were excluded, but fetuses with congenital heart disease (CHD) and normal situs were included. Antenatal data retrieved included GA at diagnosis, indication for referral, family history of any CHD or inherited arrythmia, maternal history of medication or medical conditions, fetal echocardiographic findings and sequential FHR measurements. Postnatal data included the results of 12-lead electrocardiography, echocardiography, 24-h Holter monitoring, genetic testing and final diagnosis.
RESULTS: The final cohort comprised 34 cases with persistent FSB, resulting in 33 live births and one termination of pregnancy for multiple extracardiac anomalies. Indications for referral included fetal bradycardia (n = 20), suspected CHD (n = 5), maternal anti-Ro antibodies (n = 1) and a family history of long QT syndrome (LQTS) (n = 5), cardiomyopathy (n = 2) or CHD (n = 1). Associated structural cardiac abnormalities were present in seven fetuses, including biventricular hypertrophy related to hypothyroidism (n = 2), hypertrophic cardiomyopathy (n = 1), hypoplastic left heart syndrome(n = 1), bilateral superior vena cava (n = 1), left ventricular non-compaction (LVNC) (n = 1) and a small ventricular septal defect (n = 1). Postnatal diagnoses included LQTS (n = 10), sinus-node dysfunction (SND) (n = 6), LVNC (n = 2), Albright's hereditary osteodystrophy with hypothyroidism (n = 2), histiocytoid cardiomyopathy (n = 1), catecholaminergic polymorphic ventricular tachycardia (n = 1) and myotonic muscular dystrophy (n = 1). The remaining 11 cases were classified as 'normal'. Genetic reports were available in 22 patients, of whom seven had mutations in KCNQ1, three in KCNH2, two in GNAS1 and one each in NDUFB11, RYR2, CDH7 and DMPK; one patient had a variant of unknown significance and five had normal results. Cascade testing detected affected family members in 2/4 de-novo cases of LQTS and in the one case of catecholaminergic polymorphic ventricular tachycardia. Only one neonate, who had SND (anti-Ro related), required a pacemaker at 4 years of age.
CONCLUSION: FSB could be the first manifestation of serious underlying cardiac conditions, including inherited arrhythmia syndromes, cardiomyopathy and SND, and needs careful antenatal and postnatal evaluation. Cascade testing allows the identification of potentially at-risk first-degree relatives, thereby enabling prompt intervention and appropriate management. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Nair, Doughty, Vazquez-Garcia, et al. Spectrum of potentially lethal cardiac conditions presenting with fetal sinus bradycardia: a report on 34 cases. Ultrasound Obstet Gynecol. 2026. PMID: 42333052. doi:10.1002/uog.70260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。